ShareHope Medicine Past Earnings Performance
Past criteria checks 1/6
ShareHope Medicine has been growing earnings at an average annual rate of 2.9%, while the Healthcare industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 5.4% per year. ShareHope Medicine's return on equity is 1.4%, and it has net margins of 3.2%.
Key information
2.9%
Earnings growth rate
2.4%
EPS growth rate
| Healthcare Industry Growth | 9.1% |
| Revenue growth rate | 5.4% |
| Return on equity | 1.4% |
| Net Margin | 3.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
ShareHope Medicine's (GTSM:8403) Returns On Capital Are Heading Higher
Mar 26
Is ShareHope Medicine (GTSM:8403) Using Too Much Debt?
Feb 12
ShareHope Medicine Co., Ltd. (GTSM:8403) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Jan 15What We Make Of ShareHope Medicine's (GTSM:8403) Returns On Capital
Dec 16Investors Who Bought ShareHope Medicine (GTSM:8403) Shares A Year Ago Are Now Up 26%
Nov 18Revenue & Expenses BreakdownBeta
How ShareHope Medicine makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3,873 | 125 | 700 | 12 |
| 30 Sep 23 | 3,732 | 41 | 647 | 13 |
| 30 Jun 23 | 3,818 | 145 | 687 | 16 |
| 31 Mar 23 | 3,993 | 215 | 700 | 15 |
| 31 Dec 22 | 4,137 | 294 | 716 | 16 |
| 30 Sep 22 | 4,278 | 433 | 748 | 13 |
| 30 Jun 22 | 4,162 | 360 | 695 | 7 |
| 31 Mar 22 | 3,989 | 296 | 672 | 4 |
| 31 Dec 21 | 3,850 | 233 | 649 | 0 |
| 30 Sep 21 | 3,906 | 209 | 723 | 0 |
| 30 Jun 21 | 4,145 | 302 | 730 | 0 |
| 31 Mar 21 | 4,158 | 339 | 725 | 0 |
| 31 Dec 20 | 4,099 | 248 | 710 | 0 |
| 30 Sep 20 | 3,783 | 202 | 621 | 0 |
| 30 Jun 20 | 3,388 | 145 | 581 | 0 |
| 31 Mar 20 | 3,212 | 136 | 568 | 0 |
| 31 Dec 19 | 3,124 | 195 | 555 | 0 |
| 30 Sep 19 | 3,129 | 240 | 544 | 0 |
| 30 Jun 19 | 3,214 | 199 | 546 | 0 |
| 31 Mar 19 | 3,147 | 153 | 487 | 0 |
| 31 Dec 18 | 3,057 | 146 | 444 | 0 |
| 30 Sep 18 | 2,916 | 83 | 403 | 0 |
| 30 Jun 18 | 2,732 | 87 | 343 | 0 |
| 31 Mar 18 | 2,675 | 115 | 330 | 0 |
| 31 Dec 17 | 2,617 | 124 | 319 | 0 |
| 30 Sep 17 | 2,561 | 132 | 293 | 0 |
| 30 Jun 17 | 2,468 | 132 | 292 | 0 |
| 31 Mar 17 | 2,396 | 120 | 288 | 0 |
| 31 Dec 16 | 2,330 | 123 | 285 | 0 |
| 30 Sep 16 | 2,296 | 115 | 289 | 0 |
| 30 Jun 16 | 2,243 | 113 | 288 | 0 |
| 31 Mar 16 | 2,200 | 121 | 284 | 0 |
| 31 Dec 15 | 2,135 | 217 | 282 | 0 |
| 30 Sep 15 | 2,054 | 223 | 272 | 0 |
| 30 Jun 15 | 2,013 | 217 | 260 | 0 |
| 31 Mar 15 | 1,983 | 207 | 254 | 0 |
| 31 Dec 14 | 1,969 | 106 | 247 | 0 |
| 30 Sep 14 | 1,945 | 121 | 239 | 0 |
| 30 Jun 14 | 1,912 | 117 | 239 | 0 |
| 31 Mar 14 | 1,890 | 105 | 243 | 0 |
| 31 Dec 13 | 1,865 | 89 | 244 | 0 |
| 30 Sep 13 | 1,859 | 80 | 257 | 0 |
| 30 Jun 13 | 1,876 | 72 | 263 | 0 |
Quality Earnings: 8403 has a large one-off gain of NT$34.2M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 8403's current net profit margins (3.2%) are lower than last year (7.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8403's earnings have grown by 2.9% per year over the past 5 years.
Accelerating Growth: 8403's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 8403 had negative earnings growth (-57.6%) over the past year, making it difficult to compare to the Healthcare industry average (7.6%).
Return on Equity
High ROE: 8403's Return on Equity (1.4%) is considered low.